SGEM Xtra: Are tPA Stroke Trials Really Fragile?

Date: August 18th, 2022 Reference: Munn et al. Fragility Index Meta-Analysis of Randomized Controlled Trials Shows Highly Robust Evidential Strength for Benefit of <3 Hour Intravenous Alteplase. Stroke 2022 Guest: Dr. Jeff Saver is a Professor and SA Vice Chair for Clinical Research, Carol and James Collins Chair, Department of Neurology, Director of the UCLA Comprehensive Stroke […] The post SGEM Xtra: Are tPA Stroke Trials Really Fragile? first appeared on The Skeptics Guide to Emergency Medicine.